News

FDA moves to phase out animal testing, aims for safer and cheaper drug development
The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...
Finanznachrichten18d
FDA To Phase Out Animal Testing In The Development Of Monoclonal Antibodies, Other Drugs
WASHINGTON (dpa-AFX) - The U.S. Food and Drug ... process, while reducing animal experimentation, lowering research and development or R&D costs, and eventually drug prices. According to the FDA ...
BioTechniques20h
Rare disease drug development: challenges, support and hopes for the future
In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...
CNN19d
FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration ... process, while reducing animal experimentation, lowering research and development (R&D) costs, and ultimately drug prices.” “The FDA’s animal testing ...
Contract Pharma7d
Advantages and Impact of FDA’s Plan to Phase Out Animal Testing for mAbs and Other Drugs
Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s ...
Healio8d
FDA takes steps to reduce animal testing requirements for monoclonal antibodies
According to the FDA, AI-based computational models could play a much larger role in the drug development process ... updates expected to roll out in phases.” Use of lab-grown human organoids ...
technologynetworks19d
FDA To Phase Out Animal Testing Requirements
The new approach is designed to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, lowering research and development (R&D) costs, and ultimately, drug ...